Financials

  • Market Capitalization 381.99 M
  • Employee 45
  • Founded 2019
  • CEO N/A
  • Website www.x4pharma.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1CYH8
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-2.14
Fiyat/satışlar oranı
26.03

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
3109
AUTL
Autolus Therapeutics plc - American Depositary Shares
1.48 USD-8.07%-9.20%-8.64%-44.36%393.91 M USD
3121
LRMR
Larimar Therapeutics, Inc. - Common Stock
3.73 USD-12.85%+11.34%+6.27%+6.27%387.48 M USD
3133
AVIR
Atea Pharmaceuticals, Inc. - common stock
4.74 USD-5.01%-3.27%+6.28%+47.66%379.33 M USD
3147
FENC
Fennec Pharmaceuticals Inc. - Common Stock
10.75 USD+2.48%-0.46%+18.78%+21.47%373.42 M USD

Haberler